Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plans For East African Drug Regulator Begin To Take Shape

Executive Summary

A report by the European Medicines Agency and the regulators from the East African Community has outlined the possible shape of a regional regulator in east Africa.

You may also be interested in...



Tanzania Consults On East African Community Guidelines, Including For Biosimilars

The Tanzanian drug regulator is holding a stakeholder workshop on Jan. 25 to discuss the adoption of various guidelines drafted by medicines experts within the East African Community network. On the list of documents to be discussed is a draft guideline on the registration of biosimilars.

Tanzania Consults On East African Community Guidelines, Including For Biosimilars

The Tanzanian drug regulator is holding a stakeholder workshop on Jan. 25 to discuss the adoption of various guidelines drafted by medicines experts within the East African Community network. On the list of documents to be discussed is a draft guideline on the registration of biosimilars.

Could The EMA Be A Regulatory Model For East Africa?

A meeting between the European Medicines Agency and representatives of the East African Community discussed whether the European agency could act as a model for a regulator in the six-country region.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121277

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel